Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Medtronic
(NY:
MDT
)
88.58
+0.39 (+0.44%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Medtronic
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
August 26, 2024
This MedTech leader is back on track with profitable growth.
Via
The Motley Fool
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
August 23, 2024
Palo Alto and Cava were among the earnings winners.
Via
Investor's Business Daily
Medtronic Analysts Boost Their Forecasts After Upbeat Earnings
August 21, 2024
Via
Benzinga
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
August 21, 2024
Via
Benzinga
Key Takeaways From Medtronic Analyst Ratings
August 12, 2024
Via
Benzinga
Looking Into Medtronic's Recent Short Interest
August 07, 2024
Via
Benzinga
Why NYSE:MDT qualifies as a good dividend investing stock.
August 01, 2024
Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT).
Via
Chartmill
Medtronic (MDT) Q1 2025 Earnings Call Transcript
August 20, 2024
MDT earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
August 20, 2024
It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices traded in the red at around midday trading in New York.
Via
Benzinga
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
August 20, 2024
Via
Benzinga
MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q1 2025
August 20, 2024
MDT stock results show that Medtronic beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025.
Via
InvestorPlace
Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches
August 20, 2024
Medtronic beats Q1 2025 earnings and revenue estimates with $7.9 billion in sales, driven by growth in Cardiac, Neuromodulation, and Diabetes segments. The company raises FY25 guidance, citing strong...
Via
Benzinga
Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter
August 20, 2024
Medtronic stock rose early Tuesday after the medtech company reported slightly better-than-expected results for its fiscal first quarter.
Via
Investor's Business Daily
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
August 20, 2024
The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
August 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday
August 20, 2024
Via
Benzinga
5 Dividend Growth Stocks to Buy and Hold Forever
August 19, 2024
Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios.
Via
The Motley Fool
3 Dividend Stocks to Double Up On Right Now
August 17, 2024
How does a 5.7% dividend yield sound?
Via
The Motley Fool
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
August 15, 2024
Via
Benzinga
7 Defensive Stocks to Buy as Investors Seek Shelter
August 14, 2024
With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks.
Via
InvestorPlace
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
August 14, 2024
Via
Benzinga
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
August 12, 2024
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.
Via
The Motley Fool
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
2 Dividend Stocks to Buy and Never Sell
August 06, 2024
These two are rock-solid businesses with strong dividend programs.
Via
The Motley Fool
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
3 AI-Powered Healthcare Stocks Transforming Medicine
August 02, 2024
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
July 29, 2024
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Blue-Chip Stocks to Buy for the Second Half of 2024
July 26, 2024
Despite recent scrutiny, blue-chip stocks offer a chance to capitalize on market lulls and a sector snapback
Via
InvestorPlace
7 Blue-Chip Stocks to Buy on the Dip: July 2024
July 23, 2024
Buy high-quality at relative bargain prices, if you decide to take advantage of recent weakness with these seven blue-chip stocks.
Via
InvestorPlace
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
July 19, 2024
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.